Digital Medicine Society (DiMe), a Boston-based professional society in the mHealth and telehealth space has reportedly aimed at supporting the development of digital medicine through interdisciplinary collaboration, research, teaching, and the promotion of best practices. Earlier this month, the health system had declared itself with a call for new members and unveiled three research projects.
The group involves a strategic advisory board, which features executives from Amazon, the Department of Veterans Affairs (VA), the Digital Therapeutics Alliance, Evidation Health, Novartis, Takeda and the University of North Carolina; Scientific leadership board that includes US Food and Drug Administration executives and representatives of the Icahn School of Medicine at Mount Sinai, the Michael J Fox Foundation, Pfizer and the Duke Clinical Research Institute. The group is designed to create a new forum in order to draw collaboration from a broad number of connected health aficionados. In a statement, DiMe’s interim Executive Director Jennifer Goldsack stated that “Cross-discipline cooperative networks are needed to unlock the full potential of digital medicine to improve human health.”
According to her, “DiMe provides the only professional home for individuals across digital medicine – from regulators to white-hat hackers, ethicists to engineers, and clinicians to citizen scientists. We look forward to welcoming a diverse membership to DiMe and, together, driving scientific progress and broad acceptance of digital medicine to enhance public health.” As per the report, the new group’s three research projects include – Ethical Considerations in Digital Medicine; Verification and Validation of Digital Medicine Tools; Measuring Adherence in Studies Utilizing Digital Medicine.